Natural killer activity of peripheral-blood mononuclear cells in breast cancer patients

Biomedicine and Pharmacotherapy

Volumn 63, Issue 9, 2009, Pages 703-706

  Dewan, Md Zahidunnabi ^a,b   Takada, Masahiro ^c   Terunuma, Hiroshi ^d,e   Deng, Xuewen ^d   Ahmed, Sunjida ^a   Yamamoto, Naoki ^a,b   Toi, Masakazu ^c  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d Biotherapy Institute of Japan   (Japan)

^e Tokyo Clinic Marunouchi Oazo mc   (Japan)

Author keywords

Breast cancer; NK activity; NK cell; PBMCs

Indexed keywords

CALCEIN; CD16 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CELL ACTIVITY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HISTOPATHOLOGY; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; K562 CELLS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED;

EID: 72649099514     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2009.02.003     Document Type: Article

References (21)

1. Nicolson G.L. Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis. Cancer Metastasis Rev 12 (1993) 325-343
2. Kim H., and Muller W.J. The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis. Exp Cell Res 253 (1999) 78-87
3. Hyder S.M., Chiappetta C., and Stancel G.M. Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells. Int J Cancer 92 (2001) 469-473
4. McEarchern J.A., Kobie J.J., Mack V., Wu R.S., Meade-Tollin L., Arteaga C.L., et al. Invasion and metastasis of a mammary tumor involves TGF-beta signaling. Int J Cancer 91 (2001) 76-82
5. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (2001) 50-56
6. Trinchieri G. Biology of natural killer cells. Adv Immunol 47 (1989) 187-376
7. Imai K., Matsuyama S., Miyake S., Suga K., and Nakachi K. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 356 (2000) 1795-1799
8. Ullum H., Gotzsche P.C., Victor J., Dickmeiss E., Skinhøj P., and Pedersen B.K. Defective natural immunity: an early manifestation of human immunodeficiency virus infection. J Exp Med 182 (1995) 789-799
9. Ahmad R., and Menezes J. Defective killing activity against gp120/41-expressing human erythroleukaemic K562 cell line by monocytes and natural killer cells from HIV-infected individuals. AIDS 10 (1996) 143-149
10. Scott-Algara D., and Paul P. NK cells and HIV infection: lessons from other viruses. Curr Mol Med 2 (2002) 757-768
11. Bonaparte M.I., and Barker E. Inability of natural killer cells to destroy autologous HIV-infected T lymphocytes. AIDS 17 (2003) 487-494
12. Carter P., Presta L., Gorman C.M., Ridgway J.B., Henner D., Wong W.L., et al. Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc Natl Acad Sci U S A 89 (1992) 4285-4289
13. Tokuda Y., Ohnishi Y., Shimamura K., Iwasawa M., Yoshimura M., Ueyama Y., et al. In vitro and in vivo anti-tumour effects of a humanised monoclonal antibody against c-erbB-2 product. Br J Cancer 73 (1996) 1362-1365
14. Sliwkowski M.X., Lofgren J.A., Lewis G.D., Hotaling T.E., Fendly B.M., and Fox J.A. Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin). Semin Oncol 26 (1999) 60-70
15. Carson W.E., Parihar R., Lindemann M.J., Personeni N., Dierksheide J., Meropol N.J., et al. Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2/neu-positive breast cancer cells. Eur J Immunol 31 (2001) 3016-3025
16. Clynes R.A., Towers T.L., Presta L.G., and Ravetch J.V. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets. Nat Med 6 (2000) 443-446
17. Dewan M.Z., Terunuma H., Takada M., Tanaka Y., Abe H., Sata T., et al. Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo. Breast Cancer Res Treat 104 (2007) 267-275
18. Dewan M.Z., Terunuma H., Toi M., Tanaka Y., Katano H., Deng X., et al. Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells. Cancer Sci 97 (2006) 1381-1387
19. Terunuma H., Deng X., Dewan M.Z., Fujimoto S., and Yamamoto N. Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections. Int Rev Immunol 27 (2008) 93-110
20. Whiteside T.L., and Herberman R.B. Role of human natural killer cells in health and disease. Clin Diagn Lab Immunol 1 (1994) 125-133
21. Whiteside T.L., Vujanovic N.L., and Herberman R.B. Natural killer cells and tumor therapy. Curr Top Microbiol Immunol 230 (1998) 221-244